O(6) -methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma
- PMID: 25693518
- DOI: 10.1002/ijc.29486
O(6) -methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma
Abstract
Cisplatin (CDDP) is an important anti-cancer drug commonly used in various human cancers, including nasopharyngeal carcinoma (NPC). How to overcome the drug resistance of CDDP provides opportunities to improve clinical outcomes of NPC. O(6) -methylguanine-DNA methyltransferase (MGMT) has been well-characterized to be a therapeutic determinant of O(6) -alkylguanine alkylating drugs. However, the underlying mechanism and clinical relevance between MGMT and CDDP remain poorly defined in NPC. In this study, we showed that MGMT-proficient cells were highly resistant to the cytotoxic effects of CDDP as compared to MGMT-deficient cells. Further studies showed that the platinum level of DNA after CDDP exposure was significantly lower in MGMT-proficient cells than in MGMT-deficient cells. Host cell reactivation assay revealed that MGMT protected NPC cells from CDDP-induced DNA damage by enhancing DNA repair capacity. Importantly, we demonstrated for the first time that MGMT protein directly bound to CDDP-induced DNA damages. Subsequently, CDDP-bound MGMT protein became ubiquitinated and was degraded through ubiquitin-mediated proteasome system. We further analyzed the relationship between MGMT expression and clinical survivals in a cohort of 83 NPC patients. NPC patients who received CDDP-based concurrent chemoradiotherapy (CCRT), with high MGMT expression level, exhibited shorter progression-free survival (PFS; p = 0.022) and overall survival (OS; p = 0.015), than patients with low MGMT expression level. Furthermore, high MGMT expression level remained to be an independent prognostic factor for worse PFS (p = 0.01, hazard ratio 2.23) and OS (p = 0.018, hazard ratio 2.14). Our findings suggest that MGMT protein is important to determine the efficacy of CDDP in NPC.
Keywords: MGMT; chemoradiotherapy; cisplatin; drug resistance; nasopharyngeal carcinoma.
© 2015 UICC.
Similar articles
-
O6-methylguanine-DNA methyltransferase modulates cisplatin-induced DNA double-strand breaks by targeting the homologous recombination pathway in nasopharyngeal carcinoma.J Biomed Sci. 2021 Jan 4;28(1):2. doi: 10.1186/s12929-020-00699-y. J Biomed Sci. 2021. PMID: 33397362 Free PMC article.
-
Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O6-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells.Biochem Pharmacol. 2018 Dec;158:327-338. doi: 10.1016/j.bcp.2018.10.029. Epub 2018 Oct 27. Biochem Pharmacol. 2018. PMID: 30449727
-
Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.Mol Cell Biochem. 2016 Jul;418(1-2):137-46. doi: 10.1007/s11010-016-2739-5. Epub 2016 Jun 23. Mol Cell Biochem. 2016. PMID: 27334757
-
Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy.Curr Opin Pharmacol. 2006 Aug;6(4):355-63. doi: 10.1016/j.coph.2006.03.011. Epub 2006 Jun 13. Curr Opin Pharmacol. 2006. PMID: 16777483 Review.
-
Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers.Mini Rev Med Chem. 2016;16(6):455-64. doi: 10.2174/1389557515666150722101046. Mini Rev Med Chem. 2016. PMID: 26202203 Review.
Cited by
-
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment.Int J Mol Sci. 2019 Aug 24;20(17):4136. doi: 10.3390/ijms20174136. Int J Mol Sci. 2019. PMID: 31450627 Free PMC article. Review.
-
Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.J Neurooncol. 2019 Jun;143(2):231-240. doi: 10.1007/s11060-019-03164-5. Epub 2019 Apr 22. J Neurooncol. 2019. PMID: 31011934 Free PMC article.
-
Differential Expression and Alternative Splicing of Transcripts Associated With Cisplatin-Induced Chemoresistance in Nasopharyngeal Carcinoma.Front Genet. 2020 Feb 25;11:52. doi: 10.3389/fgene.2020.00052. eCollection 2020. Front Genet. 2020. PMID: 32161615 Free PMC article.
-
Periostin overexpression is associated with worse prognosis in nasopharyngeal carcinoma from endemic area: a cohort study.Onco Targets Ther. 2018 May 29;11:3205-3213. doi: 10.2147/OTT.S163626. eCollection 2018. Onco Targets Ther. 2018. PMID: 29881294 Free PMC article.
-
Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.J Exp Clin Cancer Res. 2021 Jun 21;40(1):202. doi: 10.1186/s13046-021-02010-9. J Exp Clin Cancer Res. 2021. PMID: 34154654 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials